2007
DOI: 10.1038/sj.mt.6300037
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of D-G3139 and Its Enantiomer L-G3139 in Melanoma Cells Demonstrates Minimal In Vitro but Dramatic In Vivo Chiral Dependency

Abstract: G3139 (Genasense), an 18mer phosphorothioate antisense oligonucleotide targeted to the initiation codon region of the Bcl-2 messenger RNA (mRNA), downregulates Bcl-2 protein and mRNA expression in many cell lines. However, both the in vitro and in vivo mechanisms of action of G3139 are still uncertain. The isosequential L-deoxyribose enantiomer L-G3139, which does not downregulate Bcl-2 expression, was synthesized to study the role of the Bcl-2 protein in melanoma cells. Both D-G3139 and L-G3139 bind nonspecif… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2008
2008
2024
2024

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 42 publications
0
5
0
Order By: Relevance
“…It is well known that protein binding drives many important pharmaceutical parameters, such as toxicity, plasma half-life, tissue accumulation, cellular uptake, and activity of antisense oligonucleotides. 67 , 73 , 74 , 75 , 76 , 77 …”
Section: Discussionmentioning
confidence: 99%
“…It is well known that protein binding drives many important pharmaceutical parameters, such as toxicity, plasma half-life, tissue accumulation, cellular uptake, and activity of antisense oligonucleotides. 67 , 73 , 74 , 75 , 76 , 77 …”
Section: Discussionmentioning
confidence: 99%
“…This enantioselective cytotoxicity indicates that the enantiomers of some chiral drugs may differ both quantitatively and qualitatively in their biological activity (Liu et al, 2009;Shelley et al, 1999). Moreover, enantiomers demonstrate minimal in vitro but a dramatic in vivo chiral dependency in their anti-tumour activities (Lai et al, 2007;Brown et al, 2010). Table 3.…”
Section: Resolution Of (Rs)-1 Into Its Eantiomers: Biological Activitiesmentioning
confidence: 99%
“…This enantioselective cytotoxicity indicates that the enantiomers of some chiral drugs may differ both quantitatively and qualitatively in their biological activity (Liu et al, 2009;Shelley et al, 1999). Moreover, enantiomers demonstrate minimal in vitro but a dramatic in vivo chiral dependency in their anti-tumour activities (Lai et al, 2007;Brown et al, 2010). Once the anti-tumour activity of compounds was determined against the different breast cell lines, we carried out a selection between those that showed a great cytotoxic effect against MCF-7, including (R)-1 and (S)-1, in order to determine their influence on the several cell cycle phases.…”
Section: Discussionmentioning
confidence: 95%